Figure 1.
Pharmacokineticsof GSK2190915. Mean plasma concentration vs. time profiles for GSK2190915 in healthy Western European subjects on (A) day 1 after single dose administration of 50 mg, (), 150 mg (
), 300 mg (
), 600 mg (
) or 1000 (
) mg. Mean plasma concentration vs. time profiles for GSK2190915 in healthy Western European subjects on (B) day 1 or (C) day 11 following multiple dose administration of 10 mg (
), 50 mg, (
), 150 mg (
) or 450 mg (
).